Cephalexin
Brand name: Cephalexin
Rank #409 of 500 drugs by total cost
$21.4M
Total Cost
2,407,718
Total Claims
$21.4M
Total Cost
80,257
Prescribers
$9
Cost per Claim
1,885,174
Beneficiaries
2,550,769
30-Day Fills
$267
Avg Cost/Provider
30
Avg Claims/Provider
About Cephalexin
Cephalexin (sold as Cephalexin) was prescribed 2,407,718 times by 80,257 Medicare Part D providers in 2023, costing the program $21.4M. At $9 per claim, this is a relatively affordable medication.
Related Drugs by Cost
| # | Drug | Total Cost | Claims |
|---|---|---|---|
| 406 | Chlorthalidone (Chlorthalidone) | $21.8M | 966,780 |
| 407 | Ondansetron (Ondansetron Odt) | $21.5M | 1,261,950 |
| 408 | Asciminib Hydrochloride (Scemblix) | $21.4M | 830 |
| 409 | Cephalexin (Cephalexin) | $21.4M | 2,407,718 |
| 410 | Teprotumumab-Trbw (Tepezza) | $21.4M | 389 |
| 411 | Nystatin (Nystatin) | $21.4M | 908,177 |
| 412 | Desvenlafaxine Succinate (Desvenlafaxine Succinate Er) | $21.3M | 257,580 |
Data from CMS Medicare Part D Prescriber-Drug Public Use File, 2023. Methodology